Clipping vs coiling of posterior communicating artery aneurysms with third nerve palsy
Citation Manager Formats
Make Comment
See Comments

Abstract
The authors investigated the evolution of third nerve palsy in patients with posterior communicating artery aneurysms who underwent coiling vs clipping. There was no statistical difference of complete third nerve palsy recovery in both treatments. Both techniques were of clinical benefit. Older age, diabetes, delayed interventions, and complete third nerve palsy at presentation indicated a poor prognosis for recovery.
Treatment of third nerve palsy (TNP) from posterior communicating artery (PComA) aneurysms traditionally involves microsurgical clipping of the aneurysm.1–3 More recently, embolization with Guglielmi detachable coils (GDCs) has been advocated as an alternative treatment of aneurysms and is accepted as effective and safe for decompressing the mass effects on cranial nerves.4–7 We questioned whether coil embolization might result in complete decompression of mass effect because of the proximity of the aneurysmal sac to third nerve. On the other hand, microsurgical clipping might result in a better outcome of TNP due to disconnection of clipped aneurysm with the third nerve and complete decompression of mass effect.
Therefore, we reviewed our single-center experience over the past 5 years to determine whether surgical clipping or an endovascular procedure is better to treat PComA aneurysm with TNP. In addition, we assessed the factors attributed to the prognosis of TNP in each treatment.
Methods.
Between 2000 and 2004, 17 patients with PComA aneurysm had TNP as their presenting symptoms. None of the patients included in this study had a history of subarachnoid hemorrhage. All patients were women, with a mean age of 52.6 ± 13.0 years (range 29 to 75). The medical records of these patients were reviewed for clinical data and confirmation of aneurysm size and direction. Patient age, smoking, other microvascular risk factors (diabetes mellitus and hypertension), duration of TNP before treatment, and degree of TNP at admission were noted.
Ten of the 17 patients (58.8%) underwent endovascular coiling, and complete aneurysm closure was achieved. Seven of 17 patients (41.2%) underwent microsurgical clipping. The sac of the aneurysm was opened after clipping to free the third cranial nerve in two surgical patients. In five patients, the aneurysm adhered to the third nerve, and the dome was divided rather than dissected from the nerve to avoid nerve injury.
To identify multiple factors that would predict complete recovery of TNP, we analyzed categorical variables by the Fisher’s exact test. Comparisons between complete and incomplete patient group were made using the Mann–Whitney U test for continuous variables. All values are expressed as mean ± SD or frequency and percent where appropriate. Differences were considered significant at p < 0.05.
Results.
Follow-up data were available for all 17 patients, for periods ranging from 4 to 40 months (mean 17.6 ± 10.9). Complete resolution in nine patients (52.9%), incomplete resolution in seven (41.2%), and no change in one (5.9%) were observed. The recovery of third nerve started with the levator palpebrae muscle and was followed by the medial rectus muscle. Upgaze (superior rectus muscle) or downgaze (inferior rectus muscle) was mostly noted in incomplete recovery patients. Mild ptosis of 1 to 2 mm, compared with the contralateral eye, persisted for all patients, but this did not cause any clinical disability. All patients exhibited a sluggish direct reaction to light in the affected pupil. There was no statistical difference in complete TNP recovery as opposed to incomplete recovery with both treatment modalities (table). Both techniques are thought to be of clinical benefit for the management of PComA aneurysms with TNP.
Table Distribution of characteristics by recovery of TNP in 17 PComA patients
Endovascular coiling.
The follow-up periods ranged from 4 to 34 months (mean 15.2 ± 10.1). A history of smoking was noted for four patients. Hypertension was present in five patients, two of whom were also being treated for diabetes. The mean size of the aneurysms was 8.6 ± 4.1 mm. Seven patients (70.0%) had complete TNP, two (20.0%) had only ptosis and anisocoria, and one (10.0%) had TNP with pupillary sparing. The mean interval between the onset of TNP and treatment was 3.1 ± 2.8 days. Six patients (60.0%) had complete recovery of TNP, three (30.0%) had incomplete recovery, and one (10.0%) remained unchanged after treatment. Presence of diabetes mellitus, age, degree of TNP at presentation, and interval between the onset of TNP and treatment were significant factors of recovery of TNP (see table). Other factors, such as the presence of hypertension at presentation, size of aneurysm, and history of smoking, were not indicative of recovery of neural function in our series.
Microsurgical clipping.
The follow-up periods ranged from 6 to 40 months (mean 21.0 ± 11.8). A history of smoking was noted for one patient. Hypertension was present in four patients, one of whom was also being treated for diabetes mellitus. The mean size of the aneurysms was 9.5 ± 3.8 mm. Six patients (85.7%) had complete TNP and one (14.3%) had only ptosis and anisocoria. The mean interval between the onset of TNP and treatment was 4.0 ± 2.8 days. Three patients (42.9%) had complete recovery of third nerve function, and four (57.1%) had incomplete recovery. Patient age was the only significant factor of recovery of TNP (see table). Other factors were not indicative of recovery of neural function.
Discussion.
Impairment of third nerve function has been attributed to the direct compressive effect of an enlarging aneurysmal sac within the suprasellar cistern and to the irritant effect of an adherent aneurysm.2,8 The surgical clipping of aneurysms causing third nerve symptoms is known to be effective in relieving mass effect.1–3 Published data revealed that 62 to 90% of patients with TNP showed complete cranial nerve recovery by early surgical clipping within 2 weeks from symptom onset.1–3 Similar results have been reported in endovascular coiling.4–7 Unlike surgical clipping, endovascular treatment does not immediately resolve the mass effect of an aneurysm; the loss or reduction of aneurysmal pulsatility afforded by coils embolization may, however, be more important in the resolution of TNP caused by cerebral aneurysms than in anatomic detachment of the third nerve from an adjacent and adherent cerebral aneurysm by surgical clipping. In our results, there was no statistical difference in outcome between endovascular and neurosurgical treatment. Although mass effect remains after endovascular packing, TNP improves comparably to the recovery observed after surgical clipping. These data provide evidence that, at least for aneurysm-compressive cranial neuropathy, GDC embolization may be clinically beneficial. A large-scale randomized study will be needed to verify equivalence or detect a difference in the benefits of these two techniques.
Previous small studies of outcomes after treatment reported that timely surgery for the aneurysm was associated with a more complete recovery of TNP.8,9 There was a correlation between degree of oculomotor nerve recovery and mean time to therapeutic intervention. Age, sex, interval between onset of retrobulbar pain and TNP, size, and location were unrelated to oculomotor nerve recovery.9 Contrary to previous reports, older age and the presence of microvascular risk factors (smoking, diabetes mellitus, and hypertension) might decrease the chances of complete TNP recovery.7 In present study, the presence of diabetes, older age, delayed intervention, and complete TNP at presentation were poor prognosticators of complete recovery in the coiling group. In the microsurgical clipping group, patient age was the only significant factor for recovery of TNP. Other factors, such as the presence of hypertension, aneurysm size, history of smoking, and treatment modalities, were not indicative of recovery of neural function in our series. Our results showed that older patients who had risk factors for microvascular cranial nerve palsy were least likely to have complete recovery regardless of treatment modalities. The vascular supply to the cranial nerve that is partially compromised by diabetes, hypertension, or atherosclerosis may not be the optimal milieu for regeneration.
Footnotes
-
Disclosure: The authors report no conflicts of interest.
Received March 21, 2005. Accepted in final form September 23, 2005.
References
- 1.↵
Feely M, Kapoor S. Third nerve palsy due to posterior communicating artery aneurysm: the importance of early surgery. J Neurol Neurosurg Psychiatry 1987;50:1051–1052.
- 2.↵
- 3.
- 4.↵
Birchall D, Khangure MS, McAuliffe W. Resolution of third nerve paresis after endovascular management of aneurysms of the posterior communicating artery. AJNR Am J Neuroradiol 1999;20:411–413.
- 5.
- 6.
Mavilio N, Pisani R, Rivano C, Testa V, Spaziante R, Rosa M. Recovery of third nerve palsy after endovascular packing of internal carotid-posterior communicating artery aneurysms. Intervent Neuroradiol 2000;6:203–209.
- 7.↵
- 8.↵
- 9.↵
Letters: Rapid online correspondence
- Clipping vs coiling of posterior communicating artery aneurysms with third nerve palsy
- George KC Wong, Department of Surgery, Prince of Wales Hospital, Shatin, NT, Hong Kong SARgeorgewong@surgery.cuhk.edu.hk
- Ng SC, Tsang PK, Poon WS
Submitted February 21, 2006 - Reply from the Author
- Jung Yong Ahn, Department of Neurosurgery, 351, Yatap-dong, Pundang-gu, Sungnam, 463-712, South Koreajyahn@cha.ac.kr
Submitted February 21, 2006
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Hemiplegic Migraine Associated With PRRT2 Variations A Clinical and Genetic Study
Dr. Robert Shapiro and Dr. Amynah Pradhan
Related Articles
- No related articles found.